TriangleNCT01363479 · OUTCOME
Percentage of Patients With no Emesis
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- NUMBER
- Unit
- percentage of responders
- Interval / dispersion
- 95% Confidence Interval
- Time frame
- 0-24 hours
Analysis population: FAS i.e. patients receiving study drugs and chemotherapy
Groups in this outcome
Oral Palonosteron Plus Dexamethasone
Oral palonosetron (Aloxi 0.50 mg softgel capsule) with oral dexamethasone, both given on Day 1, prior to the scheduled start of cisplatin; then dexamethasone from Days 2 through 4. Oral palonosetron Dexamethasone
I.V. Palonosetron Plus Dexamethasone
Intravenous palonosetron (Aloxi 0.25 mg solution for injection) with oral dexamethasone, both given on Day 1, prior to the scheduled start of cisplatin; then dexamethasone from Days 2 through 4. I.V. palonosetron Dexamethasone
| Group | Source count |
|---|---|
| Oral Palonosteron Plus Dexamethasone | 369 |
| I.V. Palonosetron Plus Dexamethasone | 369 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Oral Palonosteron Plus Dexamethasone | 90.2 | Not reported | 86.8 | 92.9 | Not reported |
| I.V. Palonosetron Plus Dexamethasone | 86.7 | Not reported | 82.9 | 89.8 | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- lower Limit
- 86.8
- upper Limit
- 92.9
- value
- 90.2
- group Id
- OG001
- lower Limit
- 82.9
- upper Limit
- 89.8
- value
- 86.7
- denoms
- counts
- group Id
- OG000
- value
- 369
- group Id
- OG001
- value
- 369
- units
- Participants
- dispersion Type
- 95% Confidence Interval
- groups
- description
- Oral palonosetron (Aloxi 0.50 mg softgel capsule) with oral dexamethasone, both given on Day 1, prior to the scheduled start of cisplatin; then dexamethasone from Days 2 through 4. Oral palonosetron Dexamethasone
- id
- OG000
- title
- Oral Palonosteron Plus Dexamethasone
- description
- Intravenous palonosetron (Aloxi 0.25 mg solution for injection) with oral dexamethasone, both given on Day 1, prior to the scheduled start of cisplatin; then dexamethasone from Days 2 through 4. I.V. palonosetron Dexamethasone
- id
- OG001
- title
- I.V. Palonosetron Plus Dexamethasone
- param Type
- NUMBER
- population Description
- FAS i.e. patients receiving study drugs and chemotherapy
- reporting Status
- POSTED
- time Frame
- 0-24 hours
- title
- Percentage of Patients With no Emesis
- type
- SECONDARY
- unit Of Measure
- percentage of responders
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice